Björklund Pharma

  • Home
  • Company
  • Science & Innovation
  • Publications
  • Media
  • Contact
    • Contact Form

Management

G. Björklund, MD

Chairman and Owner of Björklund Pharma.

Dr. G. Björklund is a Scandinavian researcher and scientific advisor. He has about 270 published articles on PubMed. His current h-index, as seen on Google Scholar, is 59 and results from 10,852 citations (2023-08-31).

The independent rating agency ResearchGate ranks Björklund among the top one percent of the world’s researchers. Expertscape ranks him among the top published authors worldwide on autism spectrum disorder. G. Björklund currently ranks No. 2 in mercury in Europe and No. 4 worldwide. In selenium, he ranks No. 4 in Europe and No. 5 worldwide (2022-07-23). “Expertscape objectively ranks people and institutions by their expertise in more than 29,000 biomedical topics.” The metrics are based on published papers since 2012.

Björklund is also the founder and president of the Council for Nutritional and Environmental Medicine, an international non-profit association.

Company News

  • New COVID-19 Research Provides Insights on the Crucial Role of Zinc in Protein Targets of Drugs That Block SARS-CoV-2 Infection
  • A Possible New Medicine for Multiple Sclerosis?
  • Thymosin Beta 4 in Dry Eye Syndrome
  • The Role of Thymosin Beta 4 in COVID-19 Treatment
  • Zinc Deficiency: A Globally Widespread Ailment

RSS CONEM Autism Research

  • Zinc, Copper, and Autism Spectrum Disorder
  • Digestive Enzyme Therapy: A Possible Option in Autism Spectrum Disorder
  • Vitamin D Deficiency Correlates with Severity of Autism and Shows Improvement with Supplementation
  • ADHD, Autism, and Phenylketonuria
  • Serum Zinc and Copper Levels in Autistic Children

Company News

  • New COVID-19 Research Provides Insights on the Crucial Role of Zinc in Protein Targets of Drugs That Block SARS-CoV-2 Infection
  • A Possible New Medicine for Multiple Sclerosis?
  • Thymosin Beta 4 in Dry Eye Syndrome
  • The Role of Thymosin Beta 4 in COVID-19 Treatment
  • Zinc Deficiency: A Globally Widespread Ailment

Contact Us

Björklund Pharma AS
Toften 24
8610 Mo i Rana
Norway

Phone: +47 411 11 942
Email: info(at)bjorklundpharma.com

Copyright © 2023 Björklund Pharma AS